ARCT-032-01: Phase 1/1b study of ARCT-032 in Healthy Adult Subjects and Adults with Cystic Fibrosis (2023–2024)

Grant type:
Arcturus Therapeutics Inc
Researchers:
Funded by:
Arcturus Therapeutics Inc.